Immage Biotherapeutics Corp.
IMMG · OTC
8/31/2016 | 8/31/2015 | 9/30/2014 | 9/30/2013 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $197 | $0 | $2 | $7 |
| Short-Term Investments | $0 | $33 | -$2 | -$7 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $205 | $34 | $0 | $0 |
| Property Plant & Equip (Net) | $32 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $6 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $47 | $0 | $0 |
| Total NC Assets | $38 | $47 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $243 | $80 | $0 | $0 |
| Liabilities | – | – | – | – |
| Payables | $3 | $0 | $0 | $0 |
| Short-Term Debt | $53 | $48 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $3 | -$0 | -$0 |
| Total Curr. Liab. | $56 | $51 | $24 | $16 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $56 | $51 | $24 | $16 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $147 | $0 | $100 | $5 |
| Retained Earnings | -$303 | -$0 | -$0 | -$0 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $28 | -$122 | -$14 |
| Total Equity | $187 | $29 | -$22 | -$9 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $243 | $80 | $2 | $7 |
| Net Debt | -$144 | $48 | -$2 | -$7 |